Trials / Completed
CompletedNCT00239044
An Open Label Study to Evaluate the Tolerability and Safety of Enteric-coated Mycophenolate Sodium (EC-MPS) in Combination With Cyclosporine Microemulsion (CsA-ME) in Maintenance Renal Transplant Recipients
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 40 (planned)
- Sponsor
- Novartis Pharmaceuticals · Industry
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- —
Summary
To evaluate whether maintenance renal transplant patients on micophenolate mofetil (MMF) can be safely converted to EC-MPS, based on adverse events and acute rejection within 6 months after switching from MMF to a EC-MPS regimen.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Enteric-coated Mycophenolate sodium (EC-MPS) |
Timeline
- Start date
- 2002-12-01
- Primary completion
- 2005-07-01
- First posted
- 2005-10-14
- Last updated
- 2011-11-02
Source: ClinicalTrials.gov record NCT00239044. Inclusion in this directory is not an endorsement.